vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and Iridium Communications Inc. (IRDM). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $219.1M, roughly 1.5× Iridium Communications Inc.). HAEMONETICS CORP runs the higher net margin — 13.2% vs 9.9%, a 3.3% gap on every dollar of revenue. On growth, Iridium Communications Inc. posted the faster year-over-year revenue change (1.9% vs -2.7%). Over the past eight quarters, Iridium Communications Inc.'s revenue compounded faster (4.4% CAGR vs 0.4%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Iridium Communications Inc. is a publicly traded American company headquartered in McLean, Virginia, United States. Iridium operates the Iridium satellite constellation, a system of 80 satellites: 66 are active satellites and the remaining fourteen function as in-orbit spares. Iridium Satellites are used for worldwide voice and data communication from handheld satellite phones, satellite messenger communication devices and integrated transceivers, as well as for two-way satellite messaging se...
HAE vs IRDM — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $339.0M | $219.1M |
| Net Profit | $44.7M | $21.6M |
| Gross Margin | 59.7% | — |
| Operating Margin | 19.9% | 23.2% |
| Net Margin | 13.2% | 9.9% |
| Revenue YoY | -2.7% | 1.9% |
| Net Profit YoY | 19.3% | — |
| EPS (diluted) | $0.95 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $219.1M | ||
| Q4 25 | $339.0M | $212.9M | ||
| Q3 25 | $327.3M | $226.9M | ||
| Q2 25 | $321.4M | $216.9M | ||
| Q1 25 | $330.6M | $214.9M | ||
| Q4 24 | $348.5M | $213.0M | ||
| Q3 24 | $345.5M | $212.8M | ||
| Q2 24 | $336.2M | $201.1M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $44.7M | $24.9M | ||
| Q3 25 | $38.7M | $37.1M | ||
| Q2 25 | $34.0M | $22.0M | ||
| Q1 25 | $58.0M | $30.4M | ||
| Q4 24 | $37.5M | $36.3M | ||
| Q3 24 | $33.8M | $24.4M | ||
| Q2 24 | $38.4M | $32.3M |
| Q1 26 | — | — | ||
| Q4 25 | 59.7% | — | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — |
| Q1 26 | — | 23.2% | ||
| Q4 25 | 19.9% | 25.9% | ||
| Q3 25 | 17.9% | 30.9% | ||
| Q2 25 | 16.8% | 23.2% | ||
| Q1 25 | 21.6% | 28.1% | ||
| Q4 24 | 16.9% | 24.5% | ||
| Q3 24 | 15.0% | 25.8% | ||
| Q2 24 | 11.8% | 21.7% |
| Q1 26 | — | 9.9% | ||
| Q4 25 | 13.2% | 11.7% | ||
| Q3 25 | 11.8% | 16.4% | ||
| Q2 25 | 10.6% | 10.1% | ||
| Q1 25 | 17.5% | 14.2% | ||
| Q4 24 | 10.8% | 17.1% | ||
| Q3 24 | 9.8% | 11.5% | ||
| Q2 24 | 11.4% | 16.1% |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | $0.24 | ||
| Q3 25 | $0.81 | $0.35 | ||
| Q2 25 | $0.70 | $0.20 | ||
| Q1 25 | $1.17 | $0.27 | ||
| Q4 24 | $0.74 | $0.30 | ||
| Q3 24 | $0.66 | $0.21 | ||
| Q2 24 | $0.74 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $363.4M | — |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $911.5M | — |
| Total Assets | $2.5B | — |
| Debt / EquityLower = less leverage | 1.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $363.4M | $96.5M | ||
| Q3 25 | $296.4M | $88.5M | ||
| Q2 25 | $292.9M | $79.3M | ||
| Q1 25 | $306.8M | $50.9M | ||
| Q4 24 | $320.8M | $93.5M | ||
| Q3 24 | $299.3M | $159.6M | ||
| Q2 24 | $344.4M | $63.5M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $1.8B | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $911.5M | $462.6M | ||
| Q3 25 | $849.2M | $450.5M | ||
| Q2 25 | $882.3M | $473.6M | ||
| Q1 25 | $820.8M | $518.4M | ||
| Q4 24 | $906.9M | $576.6M | ||
| Q3 24 | $878.9M | $663.8M | ||
| Q2 24 | $905.4M | $786.7M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $2.5B | ||
| Q3 25 | $2.4B | $2.6B | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.5B | $2.6B | ||
| Q4 24 | $2.5B | $2.7B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.5B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 1.34× | 3.80× | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | 3.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $93.6M | — |
| Free Cash FlowOCF − Capex | $87.2M | — |
| FCF MarginFCF / Revenue | 25.7% | — |
| Capex IntensityCapex / Revenue | 1.9% | 13.7% |
| Cash ConversionOCF / Net Profit | 2.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $308.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $93.6M | $108.6M | ||
| Q3 25 | $111.3M | $100.8M | ||
| Q2 25 | $17.4M | $129.6M | ||
| Q1 25 | $116.6M | $61.1M | ||
| Q4 24 | $43.8M | $104.8M | ||
| Q3 24 | $48.8M | $118.6M | ||
| Q2 24 | $-27.4M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | $87.2M | $75.1M | ||
| Q3 25 | $106.3M | $79.2M | ||
| Q2 25 | $13.6M | $108.9M | ||
| Q1 25 | $100.9M | $36.5M | ||
| Q4 24 | $35.2M | $80.5M | ||
| Q3 24 | $39.4M | $100.0M | ||
| Q2 24 | $-33.1M | $68.7M |
| Q1 26 | — | — | ||
| Q4 25 | 25.7% | 35.3% | ||
| Q3 25 | 32.5% | 34.9% | ||
| Q2 25 | 4.2% | 50.2% | ||
| Q1 25 | 30.5% | 17.0% | ||
| Q4 24 | 10.1% | 37.8% | ||
| Q3 24 | 11.4% | 47.0% | ||
| Q2 24 | -9.8% | 34.2% |
| Q1 26 | — | 13.7% | ||
| Q4 25 | 1.9% | 15.7% | ||
| Q3 25 | 1.5% | 9.5% | ||
| Q2 25 | 1.2% | 9.5% | ||
| Q1 25 | 4.7% | 11.4% | ||
| Q4 24 | 2.5% | 11.4% | ||
| Q3 24 | 2.7% | 8.7% | ||
| Q2 24 | 1.7% | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | 2.09× | 4.37× | ||
| Q3 25 | 2.88× | 2.71× | ||
| Q2 25 | 0.51× | 5.90× | ||
| Q1 25 | 2.01× | 2.01× | ||
| Q4 24 | 1.17× | 2.88× | ||
| Q3 24 | 1.44× | 4.85× | ||
| Q2 24 | -0.71× | 2.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
IRDM
| Voice and data | $57.4M | 26% |
| IoT data (2) | $46.0M | 21% |
| Government | $39.5M | 18% |
| Government service revenue (5) | $27.6M | 13% |
| Subscriber equipment | $20.2M | 9% |
| Hosted payload and other data service (4) | $14.8M | 7% |
| Broadband (3) | $12.2M | 6% |
| Commercial | $1.3M | 1% |
